Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions

Yuan Yuan, Dag André Nymoen, Hiep Phuc Dong, Ola Bjørang, Ie Ming Shih, Philip S. Low, Claes G. Trope', Ben Davidson

Research output: Contribution to journalArticle

53 Scopus citations

Abstract

The objective of this study was to analyze the diagnostic and clinical role of the folate receptor-α (FOLR1) and folate receptor-γ (FOLR3) genes in effusion cytology. Expression of the FOLR1 protein product, FR-α, was additionally studied. Ninety-one effusions (71 ovarian carcinomas, 10 breast carcinomas, 10 malignant mesotheliomas) were assayed for FOLR1 and FOLR3 gene expression using quantitative polymerase chain reaction. FR-α expression was analyzed using flow cytometry. Ovarian carcinoma expression levels were analyzed for association with clinicopathologic parameters and survival. Quantitative polymerase chain reaction analysis showed significantly higher FOLR1and FOLR3 mRNA levels in ovarian carcinomas compared with both breast carcinomas and mesotheliomas (P < .001). FOLR1 and FOLR3 mRNA levels were directly interrelated in ovarian carcinoma (P < .001). FR-α protein levels were similarly higher in ovarian carcinoma compared with the 2 other cancer types (P < .001). FOLR1and FOLR3 mRNA and FR-α protein expression in ovarian carcinoma effusions showed no association with clinical parameters or survival. Our data suggest that folate receptor levels effectively differentiate ovarian carcinoma from other cancers affecting the serosal cavities and that folate receptor genes are coexpressed in this tumor. The high expression of folate receptors in ovarian carcinoma supports their validity as molecular therapeutic targets in this disease.

Original languageEnglish (US)
Pages (from-to)1453-1460
Number of pages8
JournalHuman Pathology
Volume40
Issue number10
DOIs
StatePublished - Oct 2009

Keywords

  • Breast carcinoma
  • Folate receptors
  • Malignant mesothelioma
  • Ovarian carcinoma
  • Serous effusions
  • Survival

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions'. Together they form a unique fingerprint.

Cite this